Human leukocyte antigen HLADRB1 determinants susceptibility to gastroesophageal reflux disease

- Gastroesophageal reflux disease (GERD) is characterized by diverse symptoms. There is an evidence for a genetic component to GERD as supported by familial aggregation of this disease. - To investigate whether certain human leucocyte antigen genes HLA-DRB1 are associated with GERD. - Patients and c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arquivos de gastroenterologia 2017-01, Vol.54 (1), p.41-45
Hauptverfasser: Mahdi, Batool Mutar, Hasan, Riyadh Mohamad, Salih, Wafaa Hazim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:- Gastroesophageal reflux disease (GERD) is characterized by diverse symptoms. There is an evidence for a genetic component to GERD as supported by familial aggregation of this disease. - To investigate whether certain human leucocyte antigen genes HLA-DRB1 are associated with GERD. - Patients and controls were prospectively recruited from GIT center at Al-Kindy Teaching Hospital (Baghdad-Iraq) between January 2014 and July 2016. Sixty Iraqi Arab Muslims patients with a history of heartburn and dyspepsia compared with 100 Iraqi Arab Muslims controls. All study patients and control groups underwent upper gastrointestinal endoscopic examinations and their serums were analyzed for CagA antibodies Immunoglobulin G (IgG) for H. pylori. HLA-DRB1 genotyping were done to both groups. - A total of 60 patients with erosive gastritis; GERD (Grade II and III) were evaluated, together with 100 controls. There is a significant increase of H. pylori infection (P=0.0001) in GERD patients than control group. HLA-DRB1* 15:01 was significantly increased in GERD patients in comparison with control group and an increased frequency of HLADRB1*11:01 in control group compared with patients group. - There is an association between HLA-DRB1 *15:01 in GERD patients with H. pylori positive patients.
ISSN:0004-2803
1678-4219
1678-4219
0004-2803
DOI:10.1590/S0004-2803.2017v54n1-08